Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids for Glycaemia and Cardiometabolic Disease
NCT07677995Enrolling by invitation
- Sponsor
- Ulster University
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised trial of omega-3 fatty acid in type 2 diabetes mellitus (T2DM) and prediabetes (4 arms), sponsored by Ulster University. Primary endpoint: Change in fasting glucose at 28 days. Started Sep 2026; status: enrolling by invitation.
02
Drugs
omega-3 fatty acid
03
Conditions
type 2 diabetes mellitus (T2DM)prediabetes
Beyond the preview
Go deeper on NCT07677995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677995.